Genome-wide association study (GWAS)-identified disease risk alleles do not compromise human longevity
- PMID: 20921414
- PMCID: PMC2964208
- DOI: 10.1073/pnas.1003540107
Genome-wide association study (GWAS)-identified disease risk alleles do not compromise human longevity
Abstract
A set of currently known alleles increasing the risk for coronary artery disease, cancer, and type 2 diabetes as identified by genome-wide association studies was tested for compatibility with human longevity. Here, we show that nonagenarian siblings from long-lived families and singletons older than 85 y of age from the general population carry the same number of disease risk alleles as young controls. Longevity in this study population is not compromised by the cumulative effect of this set of risk alleles for common disease.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

References
-
- Schoenmaker M, et al. Evidence of genetic enrichment for exceptional survival using a family approach: The Leiden Longevity Study. Eur J Hum Genet. 2006;14:79–84. - PubMed
-
- Terry DF, Wilcox M, McCormick MA, Lawler E, Perls TT. Cardiovascular advantages among the offspring of centenarians. J Gerontol A Biol Sci Med Sci. 2003;58:M425–M431. - PubMed
-
- Terry DF, et al. Lower all-cause, cardiovascular, and cancer mortality in centenarians’ offspring. J Am Geriatr Soc. 2004;52:2074–2076. - PubMed
-
- Westendorp RG, et al. Leiden Longevity Study Group Nonagenarian siblings and their offspring display lower risk of mortality and morbidity than sporadic nonagenarians: The Leiden Longevity Study. J Am Geriatr Soc. 2009;57:1634–1637. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources